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Aim: In this study, we investigated the sensitivity of TrichoScan, a computer-based phototrichogram, in the evaluation of diffuse hair
loss in women and the relationship between iron deficiency anemia and hair loss.
Materials and methods: We recruited 100 female patients with diffuse hair loss. In all of the patients, a 1-cm2 area of hair located in a
temporoparietal region was shortened to 0.5 mm. The shaved scalp regions were stained with black dye. The subject then waited for 12
min. Subsequently, pictures of these regions were taken with a videodermoscope and analyzed with the TrichoScan software program.
Results: The ferritin levels were markedly low in these groups. The ratio of anagen was highest in the telogen effluvium (TE) mild group,
followed by the TE severe group, and was lowest in the androgenetic alopecia (AGA) group (P < 0.05). The ratio of telogen was markedly
higher in the AGA group, and the difference was statistically significant when compared with the other 2 groups (P < 0.05).
Conclusion: The hair analysis results with the TrichoScan software were satisfactory and the results were consistent with the clinical
diagnosis. In particular, the use of TrichoScan was very successful in the differentiation between AGA and TE.
Key words: Hair growth measurement, computer, TrichoScan, telogen effluvium, ferritin

1. Introduction
Diffuse hair loss is acute or chronic generalized hair
thinning (1). Telogen effluvium (TE) is the most common
clinical form of diffuse hair loss. Several diagnostic
methods are available for hair disease; however, there
are no gold standard methods for the exact diagnosis
of hair disorders (2). TrichoScan is a computer-based
phototrichogram and its use has recently become more
popular among dermatologists. This program is loaded
onto a dermatoscope that can differentiate between vellus
and terminal hair and calculates the ratio of telogen and
anagen hair follicles. It can be used in the evaluation of
hair loss and the diagnosis of hair disorders (3). One of the
most common causes of hair loss is iron deficiency anemia
(IDA). In several studies, the level of ferritin was found to
be between 20 and 30 µg in patients with diffuse hair loss;
it has been accepted that the ideal ferritin level should be
at least 40 µg for healthy hair growth (4).
In this study, we investigated the sensitivity of
TrichoScan when it was used in the evaluation of diffuse
hair loss in the female population and the relationship
between IDA and hair loss.
* Correspondence: drhaticeuce@mynet.com
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2. Materials and methods
We recruited 100 female subjects with diffuse hair loss
who applied to our clinic. The age range was from 17 to 70
years of age. The Institutional Review Board approved the
study protocol. Those patients with psoriasis, discoid lupus
erythematosus, lichen planus, alopecia areata, diffuse
alopecia areata, and cicatricial alopecia were excluded
from the study.
A detailed history was obtained for each patient,
including systemic diseases. Patients signed an informed
consent form after the nature of the study had been fully
explained to them. Blood samples from each patient were
taken for the analysis of a complete blood count, ferritin
level, and iron binding capacity. The patient’s age, duration
of hair loss, type of hair loss, history of medications
including hormones, menstrual irregularities, and
increased hair growth were recorded. Various criteria were
used to make a clinical distinction between the different
types of hair loss. These included hair volume, hair parting,
hair density, the frontal hairline, and the frequency of
vellus hair and telogen hair.
In all patients, a 1-cm2 area of hair located in a
temporoparietal region was shortened with a razor
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(Hairliner, Wella, Germany) to 0.5 mm. Pictures (with
20× magnification) were taken from the shaved area with
a videodermoscope. A special alcohol solution was applied
to the area before the pictures were taken.
The patients were called back after 3 days for a hair pull
test (HPT), having been instructed not to take a shower
during that time. The HPT is a diagnostic method that
is routinely applied in hair loss. We formed 2 groups to
investigate whether we would be able to determine the
activity of the disease according to the HPT. The shaved
scalp regions were stained with black dye (Goldwell Top
Chic, Black, Darmstadt, Germany), and then the patient
waited for 12 min. Subsequently, this area was cleaned with
a special alcohol solution (Kodan Spray, Schülke & Mayr,
Vienna, Austria), and pictures of these regions were taken
with a videodermoscope. These pictures were analyzed
with the TrichoScan software program.
The amount of hair/cm2, the ratio of anagen to telogen
hair follicles, the number of vellus and terminal hairs, and
the ratio of vellus hair to terminal hair were calculated
with TrichoScan using the automated phototrichogram
method (Fotofinder DERMA, TeachScreen Software,
Bad Birnbach, Germany). In addition, the amount of
hair growth (0.3–2.1 mm) in 3 days was detected. The
laboratory results were added to the data, as well.
A statistical analysis of the data was performed by
factorial variant analysis (factorial ANOVA). Next, the
Duncan multiple range test was used to compare the
different groups. The Z test was used for the comparison
of the HPT results. P < 0.05 was considered statistically
significant. This statistical analysis was conducted with
SPSS 13.
3. Results
The recruited patients were classified into 3 groups: 1) TE
mild, 2) TE severe, and 3) androgenetic alopecia (AGA).
The patients’ age range was between 17 and 63 years old,
the mean age being 27.6 years of age. The patients were
separated into 2 groups according to their positive or
negative HPT results. There was no significant difference
in HPT results between the groups, and no remarkable
difference in the laboratory results was detected between
the groups. Statistical data of the patients are given in
Table 1.
The TrichoScan results of the patients are summarized
in Tables 2 and Table 3. There were statistically significant
differences in the hair density results obtained by the
TrichoScan program between the TE mild and TE severe
groups (P < 0.05), but no significant differences between
the TE severe and AGA groups.
The ratio of anagen was the highest in the TE mild
group, followed by the TE severe group, and was lowest
in the AGA group (P < 0.05). The ratio of telogen was

Table 1. Statistical data of the general descriptive features (N =
100).
Mean

Min

Max

Age

27.60

17

63

Ferritin

24.31

1.89

136.00

HB

13.32

8

16

HCT

40.20

28

46

Iron

85.22

10

311

IBC

301.59

36

474

THN

182.50

78

363

Hair/cm2

248.35

22

498

Anagen

59.74

14

80

Telogen

40.25

20

87

Vell/cm

30.68

7

69

Ter/cm2

217.63

61

447

Vellus hair

22.35

5

51

Terminal hair

160.07

55

326

0.3 mm ghn/day

38.23

12.00

158.00

0.6 mm ghn/day

14.34

4.00

40,00

1.2 mm ghn/day

8.27

0.00

22.00

2.1 mm ghn/day

8.36

0.00

45.00

2

HB: Hemoglobin, HCT: hematocrit, IBC: iron binding capacity;
THN: total hair number; Hair/cm2: hairs per cm2; Vell/cm2: vellus
hairs per cm2; Ter/cm2: terminal hairs per cm2; ghn: growing hair
number; Min: minimum; Max: maximum; N: subject number.

markedly high in the AGA group, and the difference was
statistically significant when compared with the other 2
groups (P < 0.05). The amount of hair/cm2 was higher in
the TE mild group (P < 0.05). The group with the most
hair growth was the TE mild group, which was statistically
significant when compared to the other 2 groups (P <
0.05).
In the AGA group, the ratio of anagen was statistically
different between the HPT positive and the HPT negative
groups. The ratio of anagen was higher in the HPT positive
AGA group than the negative group (P < 0.05). The ratio
of telogen was statistically different between the groups,
as well. The telogen ratio was higher in the HPT negative
group than the HPT positive group (P < 0.05). The average
of the obtained data is summarized in Table 1. Anemia was
not detected in the patients, but the level of ferritin was
markedly low.
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161.50 ± 30.89b

148.17 ± 56.79b

TE Severe

AGA

55.21 ± 14.41b

221.69 ± 42.28b
38.03 ± 22.00c

61.19 ± 12.8a

285.00 ± 94.16a

203.37 ± 77.96b

Anagen %,
mean ± SD

Hair/cm2,
mean ± SD

61.97 ±22.00a

44.79 ± 14.41b

38.81 ± 12.82b

Telogen %,
mean ± SD

23.60 ± 24.32

28.39 ± 11.97

36.09±14.96

Vellus/cm2,
mean ± SD

179.83 ± 81.4 b

193.26 ± 37.04b

257.28 ± 75.92a

Terminal/cm2,
mean ± SD

3.67 ± .51b

6.94 ± 3.97ab

10.17 ± .47a

1.2 mm ghn/3 days,
mean ± SD

0.67 ± 1.15b

4.81 ± 7.57ab

12.63 ± 12.22a

2.1 mm ghn /3 days,
mean ± SD

183.08 ±.57a

131.38 ± 35.15b

TE Severe

AGA

59.93 ± 14.36

251.22 ± 63.87a
57.79 ± 11.78

65.66 ± 11.14

255.70 ± 68.97a

180.35 ± 48.23b

Anagen %,
mean ± SD

Hair/cm2,
mean ± SD

42.23 ± 11.79b

40.07 ± 14.36b

34.25 ± 11.08a

Telogen %,
mean ± SD

26.53 ± 11.00

28.67 ± 2.40

31.81 ± 12.11

Vellus/cm2,
mean ± SD

153.84 ± 49.48b

215.77 ± 69.88a

223.86 ± 62.16a

Terminal/cm2,
mean ± SD

6.13 ± 2.90b

7.80 ± 4.90ab

9.37 ± 6.08a

1.2 mm ghn/3 days,
mean ± SD

3.88 ± 4.26b

5.93 ± 7.14b

12.89 ± 14.58a

2.1 mm ghn /3 days,
mean ± SD

SD: Standard deviation, ghn: growing hair number, TE: telogen effluvium, HPT: hair pull test; AGA: androgenetic alopecia; different lowercase letters in a column represent
significantly different means.

186.32 ± 50.20a

TE Mild

Counted hair,
mean ± SD

Table 3. Statistical data of HPT positive groups with TrichoScan

SD: Standard deviation, ghn: growing hair number, TE: telogen effluvium, HPT: hair pull test; AGA: androgenetic alopecia; different lowercase letters in a column represent
significantly different means.

214.08 ± 56.01a

TE Mild

Counted hair,
mean ± SD

Table 2. Statistical data of HPT negative groups with TrichoScan.
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Figure 1. Example of TE mild.

Figure 2. Example of TE severe.
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Figure 3. Example of AGA.

4. Discussion
An assessment of TE patients with TrichoScan, a new
method recently developed for measuring hair growth,
was evaluated for the first time in this study. TrichoScan
is also one of the few noninvasive methods that combine
epiluminescence microscopy with automatic digital image
analysis (5).
The computer-based videodermoscope is used, in
particular, for the early diagnosis of melanoma and the
differential diagnosis of pigmentary lesions. Hair and
hair follicles can also be examined by a videodermoscope
with high resolution. The structure of the hair shaft, the
differentiation of terminal hair and vellus hair, and the
separation of different hair types, including monilethrix,
pili annulati, and Netherton, can be performed with this
method, as well (6). In our study, the amount of vellus hair
was higher in the TE severe and AGA groups than the
TE mild group. The highest amount of terminal hair was
found in the TE mild group.
Hoffman investigated the hair density and the ratio
of terminal hair to vellus hair with TrichoScan in AGA
patients with and without finasteride treatment and
in a control group. The hair density and the amount
of terminal hair were significantly higher in the AGA
patients with finasteride treatment than the patients
without finasteride treatment (7). In our study, there were
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statistical differences in the hair density and the amount of
terminal hair between the TE groups and the AGA group
(P < 0.05).
The normal value of hair density shows variability in
different studies. In a prior study, normal hair density
value was determined to be 104–318 per cm2 (mean: 211
± 47.8 nonvellus hairs), calculated by a computer-based
evaluation from macroscopic photos (8). In the study
by Rushton et al., normal hair density was 181 hairs/
cm2 by phototrichogram and 237 hairs/cm2 by unit area
trichogram (9). In the study by De Villez et al., mean
normal hair density was 211 per cm2 (range: 104–318)
for nonvellus hair (10). Birch et al. calculated normal hair
density at 293 hairs/cm2 by macro photographs (11). Lee et
al. performed a 4-mm punch biopsy for detection of mean
hair numbers in a Korean female and found 14.9/4 mm
(118.63/cm2) (12). In the study by Tajima et al., the normal
hair density was 205.5 ± 50.5/cm2 by phototrichogram
(13). In our study, the normal hair density with the
TrichoScan was 285.00 ± 94.16/cm2 in the TE mild group,
221.69 ± 42.28/cm2 in the TE severe group, and 203.37 ±
77.96/cm2 in the AGA group. These findings did not show
significant differences according to HPT results. The hair
density value in the TE groups was consistent with the
previous results. The lowest hair density was detected in
the AGA group.
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Vellus hair is a nonpigmented fine hair that lacks a
medulla (14). Leroy et al. preferred to use the terminology
“fine hair” instead of vellus hair, and described a hair with
a diameter of less than 40 µm as a “fine hair” (15). In the
study by Whiting et al., a follicle with a diameter of 0.03
mm or less was called a vellus or vellus-like hair (16).
Rushton et al. defined vellus hair as a hair follicle of <40 µm
in diameter and <30 mm in length (17). In our study, the
amount of vellus hair, which was calculated by automated
phototrichogram, was 28.6 7 ± 2.40/cm2 in the TE severe
group, 36.09 ± 14.96/cm2 in the TE mild group, and 23.60
± 24.32/cm2 in the AGA group. There was no significant
difference in the amount of vellus hair among the groups.
However, a high amount of vellus hair was detected in
AGA patients in previous studies. This disparity may be
related to TrichoScan’s sensitivity, as it does not detect
hairs of less than 16 µm. Thus, a more sensitive software
program should be developed.
Of the hair follicles in healthy skin, around 85%–90% are
anagen, 13% telogen, and less than 1% catagen. Yürüker et
al. diagnosed TE if follicles were 20% telogen by trichogram
evaluation (14). In the study by Tajima et al., the patients’
pictures were taken with a videodermoscope just after
shaving the area of hair, and the percentage of anagen hair
was 84% (13). However, we think that the calculation of the
anagen/telogen ratio should wait until the hair has regrown.
In the study by Sinclair et al., horizontal skin biopsy showed
few catagen and telogen follicles, and the ratio of anagen to
telogen was 14:1.2. This histological finding showed that the
amount of telogen follicles is around 7000, and a mean of
70 telogen follicles fell off daily (18). In our study, the ratio
of anagen to telogen was 1.57 in the TE mild group, 1.23 in
the TE severe group, and 0.61 in the AGA group. There is
a significant disparity between our results and the normal,
healthy population. Our results might be meaningful
because all our patients presented with hair loss and 90%
were diagnosed with TE. There was a statistically significant
difference in the ratio of anagen to telogen between the TE
mild and AGA groups (P < 0.005). These findings did not
show significant differences according to HPT results. Our
ratio of anagen to telogen was markedly lower than normal
individual biopsy results.
In the study by Sinclair et al. involving 305 patients, the
differentiation between chronic TE and AGA was done by
3-punch biopsy. The ratio of terminal hair to vellus hair
was >8:1 in the chronic TE patients and 4:1 in the AGA

patients (18). In our study, the ratio of terminal hair to
vellus hair was >7:1 in the TE patients and >5:1 in the AGA
patients. Our results, obtained by a noninvasive method,
were similar to the biopsy results.
In previous studies, trichogram and other clinical tests,
including HPT, were more sensitive than phototrichogram
in detecting telogen hair and the diagnosis of TE (14,19).
In the study by Yürüker et al., the trichogram was more
sensitive than the phototrichogram in detecting telogen
hairs (14). In our study, the rate of telogen hair was
detected at 38% with the TrichoScan in the TE patients,
which was consistent with clinical findings.
The ideal ferritin level should be 70 µg/L in female
patients with healthy hair (19). In the study by Kantor et
al., the mean ferritin level was 23.3 µg/L in the TE group
and 62.5 µg/L in the control group (20). In another study
involving 200 patients with chronic TE, the ferritin level
was less than 40 µg/L in 65% of the patients (21). The
ferritin level should be >40 µg/L for healthy hair growth.
Iron supplementation given to patients with low ferritin
(even without IDA) significantly decreased hair loss (22).
In our study, anemia was not detected in the patients;
however, the level of ferritin was less than 40 µg/L in
72% of the patients. The mean ferritin level was 24.32 ±
2.31 µg/L. There were no differences in either the level of
ferritin or IDA between the groups.
The most common disappointment the patients with
TE voiced was their physician’s understatements about
their problems. For example, their physicians would say,
“Your hair seems normal”, or “There’s no problem with your
hair”. However, patients usually have significant anxiety
due to their hair loss. If a physician makes a decision
about their condition without sufficient evaluation, most
of the patients do not trust that decision and assume the
physician is wasting their time and money (14,23). In our
experience, the patients were usually satisfied and pleased
with computer-based examinations.
There were some restrictive factors in this study. These
factors were the small number of patients available for a
healthy control group. We could not convince healthy
individuals to try the TrichoScan application. Thus,
a control group could not be created. In conclusion,
computer-based details and careful examinations gave
reassurance to the patients who were usually anxious due
to hair loss. This reassurance is important for the patient’s
compliance with medical advice and treatment.
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